Hodkin's Lymphoma

How developers approach antibody drug conjugates

Interviewee/Contributer: Bruno Pagliara

Organisation: On-kòs Pharma Consulting

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Affimed brings new antibody to the clinic

Interviewee/Contributer: Rolf Günther

Organisation: Affimed Therapeutics AG

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Syndicate content